Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinician selected for leading female researcher development programme
Dr Abbe Crawford has been selected for the fourth round of the SUSTAIN training and development initiative.

RVC's Dr Abbe Crawford selected for fourth round of SUSTAIN

An RVC clinician has been selected for a leading female researcher development programme.

Neurology and neurosurgery clinician Dr Abbe Crawford has been selected for the fourth round of SUSTAIN, a training and development initiative, which supports female researchers in their first independent position within the scientific community.

Dr Crawfords research centres on brain abnormalities associated with Duchenne Muscular Dystrophy (DMD), the most common lethal genetic disorder diagnosed in childhood. Using various techniques to study brain function in the diseased state, her research aims to understand why DMD patients show abnormal brain function and to ultimately develop therapeutic strategies to overcome these brain deficits.

Being a member of SUSTAIN will allow Dr Crawford to join a network of early-career female researchers. The programme runs for one year and will include mentoring from Academy Fellows, peer-coaching and a series of bespoke training workshops.

“I feel very lucky to be joining the SUSTAIN programme. It is a wonderful opportunity to become part of a supportive cohort of like-minded female researchers and to receive training from leading experts in a range of key, yet often undertaught, areas including mentorship, negotiation, and digital resilience,” said Dr Crawford.

“This course comes at an ideal time as I try to develop an independent research programme through my work with colleagues at the Royal Veterinary College. I am confident that the skills, knowledge and support network I will gain from this course will build upon the RVC’s ongoing support and allow me to develop and thrive as I begin this exciting chapter of my career.”

Professor Jonathan Elliott, vice-principal for research and innovation at the RVC, added: “We are incredibly excited about Abbe’s selection in this programme and take great pride in watching her research and career go from strength-to-strength.

“The RVC is renowned for its research excellence and we are committed to supporting all of our colleagues as they pursue their own personal development. In particular, there is an urgent need to develop the research careers of veterinary clinical scientists who work at the interface between veterinary and human health in the way that Abbe is doing”.

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.